ArticleCancers2023

ABL1/2 and DDR1 Drive MEKi Resistance in NRAS-Mutant Melanomas by Stabilizing RAF/MYC/ETS1 and Promoting RAF Homodimerization.

Anastasia Lyon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.